Official Title
Impact of the Covid19 Pandemic on the Organization of Healthcare in France
Brief Summary

The 2020 COVID-19 pandemic, which began spreading on January 24, 2020 in France, hasrequired a profound and rapid reorganization of the health system, based in particular oninternal hospital reorganizations of front-line establishments, deprogramming ofnon-urgent activities, and transfers of non-covid19 patients to 2nd line facilities.Beyond the immediate impact on the management of patients infected with COVID-19, thisreorganization may have reduced the capacity of management for patients requiring urgentor semi-urgent intervention, or may have postponed some necessary care. The isolation ofpatients at home may also have resulted in lower compliance to therapy and medicaltreatments and may have contributed to decompensation.At the end of this crisis, the different organizational responses in France should beevaluated to identify the consequences and the areas for improvement in order to beprepared for future exceptional health situations. This investigation on healthcaresystems confronted to an exceptional health situation thus seeks to determine if theprofound reorganizations implemented during this health crisis have indirect effects onthe performance of care, in particular if there is a destabilization of the care systems(emergency, semi-emergency and chronic), a loss of chance for the patients and ifinnovative care paths have emerged.

Unknown status
COVID-19
Eligibility Criteria

Inclusion Criteria:

- Patients with one of these three types of chronic diseases (Prevention Quality
Indicators of the Agency for Healthcare Research and Quality): heart failure,
diabetes, chronic obstructive pulmonary disease.

- All French adult patients suffering from the studied chronic diseases, covered by
the Health Insurance and living in metropolitan France are included.

Exclusion Criteria:

- Patients under 18 years of age or with incomplete or inconsistent data on the
"Système National des Données de Santé", or with a symptomatic COVID-19 diagnosis.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

Assistance Publique Hôpitaux de Marseille
Marseille, France

Investigator: Laurent BOYER, MD
Contact: +33491385266
laurent.boyer@ap-hm.fr

Contacts

Laurent BOYER
04 91 38 75 83
laurent.boyer@ap-hm.fr

Emilie GARRIDO-PRADALIE
Emilie.GARRIDO-PRADALIE@ap-hm.fr

Assistance Publique Hopitaux De Marseille
NCT Number
MeSH Terms
COVID-19